-transparent.png){kind=logo}
The effectiveness of 4 X 500 ml dextran-40 infusions (Rheomacrodex) for the prevention of postoperative deep vein thrombosis was evaluated in a prospective, controlled, randomized study in urological and general surgical patients. The 125I-fibrinogen test was performed daily in all patients. 36 of 100 control patients developed deep vein thrombosis, but only 20 out of 92 (21.7%) did so in the dextran group (P less than 0.05). The number of patients showing bilateral deep vein thrombosis was significantly reduced under dextran prophylaxis (P less than 0.01). No side effects of dextran prophylaxis were seen.
Related Publications
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
July 1987,
JAMA,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
November 1977,
Langenbecks Archiv fur Chirurgie,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
July 1981,
Dermatologische Monatschrift,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
September 1995,
The European journal of surgery = Acta chirurgica,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
February 2024,
Cureus,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
January 2007,
Phlebology,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
November 1973,
Munchener medizinische Wochenschrift (1950),
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
April 1995,
Thrombosis and haemostasis,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
January 1999,
Seminars in thrombosis and hemostasis,
O Hutter, and
F Duckert, and
R Fridrich, and
U F Gruber
February 1978,
MMW, Munchener medizinische Wochenschrift,
